SYNTHESIS AND INVITRO CHARACTERIZATION OF CELECOXIB EMULGEL

http://dx.doi.org/10.31703/gpsr.2016(I-I).03      10.31703/gpsr.2016(I-I).03      Published : Dec 2016
Authored by : Zahrah Hasan , Maryam Anwar , Muhammad Farhan Sohail , Tanveer Ahmed Khan

03 Pages : 17-28

References

  • Aiyalu, R., Govindarjan, A., & Ramasamy, A. (2016). Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model. Brazilian Journal of Pharmaceutical Sciences, 52(3), 493-507.
  • Avouac, B., Combe, B., & Darne, B. (2003). Prescription of NSAIDs in patients treatment with platelet inhibitors or anticoagulants. Presse medicale (Paris, France: 1983), 32(37 Pt 2), S38-43.
  • Basera, K., Kothiyal, P., & Gupta, P. (2015). Nanoemulgel: a novel formulation approach for topical delivery of hydrophobic drugs. World Journal of Pharmacy and Pharmaceutical Sciences, 4(10), 1871-1886.
  • Day, R. O., & Graham, G. G. (2004). The vascular effects of COX-2 selective inhibitors. Australian Prescriber, 27(6), 142-145.
  • Dworkin, R. H., O'connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., . . . Nurmikko, T. J. (2007). Pharmacologic management of neuropathic pain: evidence- based recommendations. Pain, 132(3), 237- 251.
  • Garg, A., Aggarwal, D., Garg, S., & Singla, A. K. (2002). Spreading of semisolid formulations: an update. Pharmaceutical Technology North America, 26(9), 84-84.
  • Hebbes, C. (2016). Non-opioid analgesics. Anaesthesia & Intensive Care Medicine, 17(9), 469-472.
  • Islam, M. T., Rodriguez-Hornedo, N., Ciotti, S., & Ackermann, C. (2004). Rheological characterization of topical carbomer gels neutralized to different pH. Pharmaceutical research, 21(7), 1192-1199.
  • Joshi, B., Singh, G., Rana, A., Saini, S., & Singla, V. (2011). Emulgel: a comprehensive review on the recent advances in topical drug delivery. Int Res J Pharm, 2(11), 66-70.
  • Kadhim, A. A., Seah, B. T., & Zubair, A. M. (2016). Influence of magnetic field on blood viscosity. Advances in Environmental Biology, 10(1), 107- 111.
  • Khullar, R., Kumar, D., Seth, N., & Saini, S. (2012). Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi pharmaceutical journal, 20(1), 63-67.
  • Kumar, L., & Verma, R. (2010). In vitro evaluation of topical gel prepared using natural polymer. International journal of drug delivery, 2(1).
  • Kumar, L., & Verma, R. (2011). Chemical stability studies of bioadhesive topical gel. International Journal Pharmacy and Pharmaceutical Scinces, 3(1), 101-104.
  • Lee, C., Koo, J., & Wolverton, S. (2007). Comprehensive dermatologic drug therapy. Comprehensive dermatologic drug therapy, 11.
  • Maheshwar, M. A REVIEW ARTICLE ON MEASUREMENT OF VISCOSITY.
  • Mathew, S. T., Devi S, G., Prasanth, V., & Vinod, B. (2011). Efficacy and safety of COX-2 inhibitors in the clinical management of arthritis: Mini review. ISRN pharmacology, 2011.
  • Mohamed, M. I. (2004). Optimization of chlorphenesin emulgel formulation. The AAPS journal, 6(3), 81-87.
  • Palacio, M. L., & Bhushan, B. (2012). Bioadhesion: a review of concepts and applications. Phil. Trans. R. Soc. A, 370(1967), 2321-2347.
  • Panwar, A., Upadhyay, N., Bairagi, M., Gujar, S., Darwhekar, G., & Jain, D. (2011). Emulgel: a review. Asian J Pharm Life Sci, 2231, 4423.
  • Singh Malik, D., Mital, N., & Kaur, G. (2016). Topical drug delivery systems: a patent review. Expert opinion on therapeutic patents, 26(2), 213-228.
  • Singla, V., Saini, S., Joshi, B., & Rana, A. (2012). Emulgel: A new platform for topical drug delivery. International Journal of Pharma and Bio Sciences, 3(1), 485-498.
  • Subacute, C., & Chronic, C. DermNet NZ
  • Thangamani, S., Younis, W., & Seleem, M. N. (2015). Repurposing celecoxib as a topical antimicrobial agent. Frontiers in microbiology, 6, 750.
  • Vinod, V., & Vani, C. S. V. Overview on transdermal drug delivery by semisolid systems: Emulgel.

References

  • Aiyalu, R., Govindarjan, A., & Ramasamy, A. (2016). Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model. Brazilian Journal of Pharmaceutical Sciences, 52(3), 493-507.
  • Avouac, B., Combe, B., & Darne, B. (2003). Prescription of NSAIDs in patients treatment with platelet inhibitors or anticoagulants. Presse medicale (Paris, France: 1983), 32(37 Pt 2), S38-43.
  • Basera, K., Kothiyal, P., & Gupta, P. (2015). Nanoemulgel: a novel formulation approach for topical delivery of hydrophobic drugs. World Journal of Pharmacy and Pharmaceutical Sciences, 4(10), 1871-1886.
  • Day, R. O., & Graham, G. G. (2004). The vascular effects of COX-2 selective inhibitors. Australian Prescriber, 27(6), 142-145.
  • Dworkin, R. H., O'connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., . . . Nurmikko, T. J. (2007). Pharmacologic management of neuropathic pain: evidence- based recommendations. Pain, 132(3), 237- 251.
  • Garg, A., Aggarwal, D., Garg, S., & Singla, A. K. (2002). Spreading of semisolid formulations: an update. Pharmaceutical Technology North America, 26(9), 84-84.
  • Hebbes, C. (2016). Non-opioid analgesics. Anaesthesia & Intensive Care Medicine, 17(9), 469-472.
  • Islam, M. T., Rodriguez-Hornedo, N., Ciotti, S., & Ackermann, C. (2004). Rheological characterization of topical carbomer gels neutralized to different pH. Pharmaceutical research, 21(7), 1192-1199.
  • Joshi, B., Singh, G., Rana, A., Saini, S., & Singla, V. (2011). Emulgel: a comprehensive review on the recent advances in topical drug delivery. Int Res J Pharm, 2(11), 66-70.
  • Kadhim, A. A., Seah, B. T., & Zubair, A. M. (2016). Influence of magnetic field on blood viscosity. Advances in Environmental Biology, 10(1), 107- 111.
  • Khullar, R., Kumar, D., Seth, N., & Saini, S. (2012). Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi pharmaceutical journal, 20(1), 63-67.
  • Kumar, L., & Verma, R. (2010). In vitro evaluation of topical gel prepared using natural polymer. International journal of drug delivery, 2(1).
  • Kumar, L., & Verma, R. (2011). Chemical stability studies of bioadhesive topical gel. International Journal Pharmacy and Pharmaceutical Scinces, 3(1), 101-104.
  • Lee, C., Koo, J., & Wolverton, S. (2007). Comprehensive dermatologic drug therapy. Comprehensive dermatologic drug therapy, 11.
  • Maheshwar, M. A REVIEW ARTICLE ON MEASUREMENT OF VISCOSITY.
  • Mathew, S. T., Devi S, G., Prasanth, V., & Vinod, B. (2011). Efficacy and safety of COX-2 inhibitors in the clinical management of arthritis: Mini review. ISRN pharmacology, 2011.
  • Mohamed, M. I. (2004). Optimization of chlorphenesin emulgel formulation. The AAPS journal, 6(3), 81-87.
  • Palacio, M. L., & Bhushan, B. (2012). Bioadhesion: a review of concepts and applications. Phil. Trans. R. Soc. A, 370(1967), 2321-2347.
  • Panwar, A., Upadhyay, N., Bairagi, M., Gujar, S., Darwhekar, G., & Jain, D. (2011). Emulgel: a review. Asian J Pharm Life Sci, 2231, 4423.
  • Singh Malik, D., Mital, N., & Kaur, G. (2016). Topical drug delivery systems: a patent review. Expert opinion on therapeutic patents, 26(2), 213-228.
  • Singla, V., Saini, S., Joshi, B., & Rana, A. (2012). Emulgel: A new platform for topical drug delivery. International Journal of Pharma and Bio Sciences, 3(1), 485-498.
  • Subacute, C., & Chronic, C. DermNet NZ
  • Thangamani, S., Younis, W., & Seleem, M. N. (2015). Repurposing celecoxib as a topical antimicrobial agent. Frontiers in microbiology, 6, 750.
  • Vinod, V., & Vani, C. S. V. Overview on transdermal drug delivery by semisolid systems: Emulgel.

Cite this article

APA

    APA : Hasan, Z., Anwar, M., & Sohail, M. F. (2016). Synthesis and In-vitro Characterization of Celecoxib Emulgel. Global Pharmaceutical Sciences Review, I(I), 17-28. https://doi.org/10.31703/gpsr.2016(I-I).03

CHICAGO

    CHICAGO : Hasan, Zahrah, Maryam Anwar, and Muhammad Farhan Sohail. 2016. "Synthesis and In-vitro Characterization of Celecoxib Emulgel." Global Pharmaceutical Sciences Review, I (I): 17-28 doi: 10.31703/gpsr.2016(I-I).03

HARVARD

    HARVARD : HASAN, Z., ANWAR, M. & SOHAIL, M. F. 2016. Synthesis and In-vitro Characterization of Celecoxib Emulgel. Global Pharmaceutical Sciences Review, I, 17-28.

MHRA

    MHRA : Hasan, Zahrah, Maryam Anwar, and Muhammad Farhan Sohail. 2016. "Synthesis and In-vitro Characterization of Celecoxib Emulgel." Global Pharmaceutical Sciences Review, I: 17-28

MLA

    MLA : Hasan, Zahrah, Maryam Anwar, and Muhammad Farhan Sohail. "Synthesis and In-vitro Characterization of Celecoxib Emulgel." Global Pharmaceutical Sciences Review, I.I (2016): 17-28 Print.

OXFORD

    OXFORD : Hasan, Zahrah, Anwar, Maryam, and Sohail, Muhammad Farhan (2016), "Synthesis and In-vitro Characterization of Celecoxib Emulgel", Global Pharmaceutical Sciences Review, I (I), 17-28

TURABIAN

    TURABIAN : Hasan, Zahrah, Maryam Anwar, and Muhammad Farhan Sohail. "Synthesis and In-vitro Characterization of Celecoxib Emulgel." Global Pharmaceutical Sciences Review I, no. I (2016): 17-28. https://doi.org/10.31703/gpsr.2016(I-I).03